Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment-Reference-Cited by-同舟云学术

Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment

Published:2022-04 Issue: Volume:115 Page:106714
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Bikdeli Behnood,Khairani Candrika D.,Barns Briana M.,Rosovsky Rachel P.,Jimenez David,Monreal Manuel,Sylvester Katelyn W.,Middeldorp Saskia,Bates Shannon M.,Krumholz Harlan M.,Goldhaber Samuel Z.,Hunt Beverley J.,Piazza Gregory

Funder

Brigham and Women's Hospital

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference48 articles.

1. The lancet women and cardiovascular disease commission: reducing the global burden by 2030;Vogel;Lancet,2021

2. Variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study design;Lichtman;Circ. Cardiovasc. Qual. Outcomes,2010

3. Women’s participation in cardiovascular clinical trials from 2010 to 2017;Jin;Circulation,2020

4. Design and rationale of the comprehensive evaluation of risk factors in older patients with AMI (SILVER-AMI) study;Dodson;BMC Health Serv. Res.,2014

5. Cardiovascular disease in women committee leadership council, increasing participation of women in cardiovascular trials: JACC council perspectives;Cho;J. Am. Coll. Cardiol.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias;Research and Practice in Thrombosis and Haemostasis;2023-05

3. Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study;Thrombosis Research;2022-06